An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People.
National Clinical Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2014 Sep. (NICE Clinical Guidelines, No. 183.)
Top results in this bookTable of Contents
Omalizumab Treatment for Adults and Children with Allergic Asthma: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Mar 9.
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma.
National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma.
Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
CADTH Canadian Drug Expert Committee Recommendation: Benralizumab (Fasenra — Astrazeneca Canada Inc.): Indication: Severe Eosinophilic Asthma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach: 2010 Version.
Geneva: World Health Organization; 2010.
CADTH Canadian Drug Expert Committee Recommendation: Indacaterol/Mometasone Furoate (Atectura Breezhaler — Novartis Pharmaceuticals Canada Inc.): Indication: Asthma maintenance (adults, children aged 12 or older) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Nov.
CADTH Canadian Drug Expert Committee Recommendation: Indacaterol/Glycopyrronium/Mometasone Furoate (Enerzair Breezhaler — Novartis Pharmaceuticals Canada Inc.): Indication: Asthma maintenance, adults [Internet].
CADTH Canadian Drug Expert Committee Recommendation: Fluticasone Propionate (Aermony Respiclick — Teva Canada Innovation): Indication: Maintenance treatment of asthma in patients 12 years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Dec 21.
Manual on Paediatric HIV Care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children.
Geneva: World Health Organization; 2011.
Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision.
Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision.
Calaspargase Pegol (Asparlas): CADTH Reimbursement Recommendation: Indication: As a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 to 21 years [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
CADTH Canadian Drug Expert Committee Recommendation: Dupilumab (Dupixent — Sanofi-Aventis Canada Inc.): Indication: Atopic dermatitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jul.
Pegvaliase (Palynziq): CADTH Reimbursement Recommendation: Indication: For the treatment of patients with phenylketonuria aged 16 years and older who have inadequate blood phenylalanine control (blood phenylalanine levels greater than 600 µmol/L) on existing management [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Nivolumab (Opdivo): CADTH Reimbursement Recommendation: Indication: In combination with fluoropyrimidine- and platinum-containing chemotherapy, for the treatment of adult patients with human epidermal growth factor receptor 2–negative advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Crisantaspase Recombinant (Rylaze): CADTH Reimbursement Recommendation: Indication: As a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 year or older who have developed hypersensitivity to E. coli-derived asparaginase [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.
CADTH Canadian Drug Expert Committee Recommendation: Crisaborole (Eucrisa — Pfizer Canada Inc.): Indication: For topical treatment of mild-to-moderate atopic dermatitis in patients two years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Apr.
Incorporating Alcohol Pharmacotherapies Into Medical Practice.
Center for Substance Abuse Treatment.
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. (Treatment Improvement Protocol (TIP) Series, No. 49.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on